SynVivo Appoints Dr. Richard Eglen to Board of DirectorsHUNTSVILLE, Ala., May 21, 2025 (GLOBE NEWSWIRE) -- SynVivo, a pioneering organ-on-chip company developing advanced microfluidic platforms that replicate human tissue microenvironments for drug discovery, today announced the appointment of Dr. Richard Eglen as a non-executive member of its Board of Directors.
